Serstech
17.9.2026 18:40:00 CEST | Globenewswire | Press release
Serstech receives 10.7 MSEK order from US partner WS Darley and co
Serstech receives 10.7 MSEK order from US partner WS Darley and co
Serstech has received an order from its US partner WS Darley and co valued at 10.7 MSEK. The order comprises instruments and software and will be delivered and invoiced during the fourth quarter of 2026. The end customer is the US Army.
For further information, please contact:
Stefan Sandor,
CEO, Serstech AB Phone: +46 739 606 067
Email: ss@serstech.com
or
Arve Nilsson,
Chairman of the Board, Serstech AB Phone: +45 40 35 82 65
Email: arve.nilsson@serstech.com
or visit: www.serstech.com
This is information that Serstech AB (publ.) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above at 18:40 CET on September 17, 2026.
Certified advisor to Serstech is Svensk Kapitalmarknadsgranskning AB (SKMG).
About Serstech
Serstech delivers solutions for chemical identification and has customers around the world, mainly in the safety and security industry. Typical customers are customs, police authorities, security organizations and first responders. The solutions and technology are however not limited to security applications and potentially any industry using chemicals of some kind could be addressed by Serstech’s solution. Serstech’s head office is in Sweden and all production is done in Sweden.
Serstech is traded at Nasdaq First North Growth Market and more information about the company can be found at www.serstech.com
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Chint Global17.9.2026 21:05:04 CEST | Press release
CHINT Presents Advanced Grid Solutions for Europe in Paris
Scandinavian Investment Group A/S17.9.2026 20:52:10 CEST | Pressemeddelelse
Ledende medarbejders handel med aktier
F. Hoffmann-La Roche Ltd17.9.2026 20:30:00 CEST | Press release
Roche announces grand opening of its Innovation Center Boston to drive advancements in Cardiovascular, Renal and Metabolic diseases
Solvay S.A.17.9.2026 17:45:00 CEST | Press release
Participation notifications by Citigroup Inc.
Novo Nordisk A/S17.9.2026 16:14:20 CEST | Press release
Novo: CHMP recommends EU approval of FREHEMGO® (denecimig), the first factor VIIIa mimetic offering monthly, once every two weeks and weekly dosing in a pre-filled pen, for the treatment of haemophilia A
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom